Filing Flows › Rockwell Medical (RMTI) › Q4 2024
Rockwell Medical (RMTI) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 20, 2025
Rockwell Medical (RMTI) reported revenue of $24.7M for the fourth quarter 2024 (Q4 2024), +12% from a year earlier and -13% from the quarter before. Operating margin was -2.1%, net loss $756K (3.1% of revenue).
Rockwell Medical, Q4 2024: revenue $24.7M (+12% year over year), operating margin -2.1%, net loss $756K, operating cash flow $865K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.7M | -13% | +12% |
| Operating profit | −$519K | — | — |
| Net earnings | −$756K | — | — |
| Operating cash flow | $865K | -80% | — |
| Free cash flow | $470K | -88% | — |
What changed
Revenue was $24.7M in Q4 2024, up 12% year over year and down 13% from the previous quarter. Concentrate Products was the largest line at 100% of revenue.
Gross margin was 14.7%, up 1.7 points from a year earlier. Operating costs exceeded revenue by $519K, an operating margin of -2.1%. Operating expenses grew 21% against revenue growth of 12%. The fastest-growing cost line was Sales & marketing (+56%). The quarter ended with a net loss of $756K, after a profit of $1.7M the previous quarter.
Operating cash flow was $865K. Non-cash charges added back $543K of depreciation and amortization and $382K of share-based compensation. Working capital and other items added $696K. Capital expenditures of $395K left free cash flow of $470K.
Questions
What was Rockwell Medical's revenue in the fourth quarter 2024?
Rockwell Medical (RMTI) reported revenue of $24.7M for the fourth quarter 2024 (Q4 2024), +12% from a year earlier and -13% from the quarter before.
Was Rockwell Medical profitable in the fourth quarter 2024?
Operating loss was $519K (-2.1% of revenue) and net loss $756K.
Source: Rockwell Medical 10-K on SEC EDGAR.